We are live on ! Find out more
Nisa Investment Advisors

Nisa Investment Advisors Portfolio holdings

AUM $27B
1-Year Est. Return 24.49%
This Fund
S&P 500
This Quarter Est. Return
+21.7%
1 Year Est. Return
+24.49%
3 Year Est. Return
+88.53%
5 Year Est. Return
+114.58%
10 Year Est. Return
+419.26%
AUM
$10.9B
AUM Growth
+$1.89B
Cap. Flow
+$164M
Cap. Flow %
1.51%
Top 10 Hldgs %
21.79%
Holding
2,159
New
88
Increased
943
Reduced
632
Closed
97

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$14.4M
2
META icon
Meta Platforms (Facebook)
META
+$13.8M
3
ABBV icon
AbbVie
ABBV
+$10.8M
4
AMZN icon
Amazon
AMZN
+$10.7M
5
GILD icon
Gilead Sciences
GILD
+$9.53M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$18.9M
2
RTN
Raytheon Company
RTN
+$12.4M
3
CB icon
Chubb
CB
+$5.57M
4
MSFT icon
Microsoft
MSFT
+$5.33M
5
PG icon
Procter & Gamble
PG
+$5.19M

Sector Composition

Rank Sector Weight
1 Technology 22.29%
2 Healthcare 15.34%
3 Financials 12.17%
4 Consumer Discretionary 8.84%
5 Communication Services 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TK icon
2026
Teekay
TK
$985M
$4K ﹤0.01%
+1,700
New +$5.2K
MRNS
2027
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$4K ﹤0.01%
430
EXPR
2028
DELISTED
Express, Inc.
EXPR
$4K ﹤0.01%
118
+15
+15% +$553
ROCC
2029
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$4K ﹤0.01%
+390
New +$3.02K
CLVS
2030
DELISTED
Clovis Oncology, Inc.
CLVS
$4K ﹤0.01%
645
+175
+37% +$1.32K
GPOR
2031
DELISTED
Gulfport Energy Corp.
GPOR
$4K ﹤0.01%
+4,070
New +$6.07K
AVTX icon
2032
Avalo Therapeutics
AVTX
$983M
0
BABA icon
2033
Alibaba
BABA
$308B
$3K ﹤0.01%
16
CBUS icon
2034
Cibus
CBUS
$138M
$3K ﹤0.01%
14
HMC icon
2035
Honda
HMC
$41.3B
$3K ﹤0.01%
117
+13
+13% +$316
HAPN
2036
Happen Inc
HAPN
$2.24B
$3K ﹤0.01%
724
-7,400
-91% -$46.1K
MDRR
2037
Medalist Diversified Inc
MDRR
$3K ﹤0.01%
96
+25
+35% +$726
NTR icon
2038
Nutrien
NTR
$30.7B
$3K ﹤0.01%
78
-104
-57% -$3.62K
IMDX
2039
Insight Molecular Diagnostics
IMDX
$156M
$3K ﹤0.01%
79
+33
+72% +$1.7K
RMTI icon
2040
Rockwell Medical
RMTI
$28.2M
$3K ﹤0.01%
15
NETI
2041
DELISTED
Eneti Inc.
NETI
$3K ﹤0.01%
200
KDNY
2042
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$3K ﹤0.01%
272
JNCE
2043
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$3K ﹤0.01%
500
RUBY
2044
DELISTED
Rubius Therapeutics, Inc
RUBY
$3K ﹤0.01%
480
LJPC
2045
DELISTED
La Jolla Pharmaceutical Company
LJPC
$3K ﹤0.01%
590
-170
-22% -$1.03K
CNI icon
2046
Canadian National Railway
CNI
$76.6B
$2K ﹤0.01%
21
+5
+31% +$416
GOGO icon
2047
Gogo Inc
GOGO
$492M
$2K ﹤0.01%
650
LXRX icon
2048
Lexicon Pharmaceuticals
LXRX
$1.1B
$2K ﹤0.01%
760
QUAD icon
2049
Quad
QUAD
$525M
$2K ﹤0.01%
500
-32,000
-98% -$98K
SXC icon
2050
SunCoke Energy
SXC
$797M
$2K ﹤0.01%
800
-21,000
-96% -$67.1K

Similar funds

Nisa Investment Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, Nisa Investment Advisors held 2,159 positions worth $10.9B, up 21% from $8.98B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nisa Investment Advisors's Q2 2020 filing shows 88 new, 943 increased, 632 reduced and 97 closed positions. Its largest new stake was Otis Worldwide: 129,485 shares worth $7.36M. The largest sale was Allergan plc, an estimated $18.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Nisa Investment Advisors's largest Q2 2020 buy was Otis Worldwide: 129,485 shares worth $7.36M.
  • Nisa Investment Advisors added most to Apple in Q2 2020, an estimated $14.4M increase.
  • Nisa Investment Advisors's biggest Q2 2020 reduction was Chubb, cutting an estimated $5.57M.
  • Nisa Investment Advisors fully exited Allergan plc in Q2 2020, selling an estimated $18.9M.
  • Nisa Investment Advisors's ten largest holdings make up 22% of its $10.9B portfolio in Q2 2020.
  • Nisa Investment Advisors opened 88 new positions and closed 97 in Q2 2020.
  • Nisa Investment Advisors's portfolio value rose 21% quarter-over-quarter to $10.9B.

Based on Nisa Investment Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.